Content-led, claims-safe

The Journal

Advertising restrictions on health claims mean we grow through education first. Everything here is reviewed by our clinical team before publishing.

GLP-16 min

Titration is the whole game

Why the ramp schedule your physician sets matters more than the molecule you started with, and how side effects usually trace back to pace.

Read article
Compliance8 min

Why 'research use only' vials exist

A plain-language look at the regulatory gap gray-market sellers operate in, and what a prescription actually changes for the patient.

Read article
Longevity5 min

Reading your IGF-1 panel

What a baseline growth-factor panel tells your physician before a secretagogue protocol is written — and what it doesn't.

Read article
Recovery9 min

BPC-157 and TB-500, honestly

The state of the evidence, what patients report, and why we won't publish before-and-after photos.

Read article
Creator seriesVideo

Sitting in on a physician review

We filmed a full intake review with a prescriber, minus the patient details. Here's what they look for first.

Read article
Skin4 min

Copper peptides beyond the serum aisle

GHK-Cu shows up in every skincare line. What a compounded, prescribed formulation does differently.

Read article

Get one clinical read a week

No hype, no dosing advice — just what our physicians are reading and why.

Start intake instead